Crude Ethanol Extract of Pithecellobium ellipticum as a Potential Lipid-Lowering Treatment for Hypercholesterolaemia.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4009285)

Published in Evid Based Complement Alternat Med on April 15, 2014

Authors

Janet P-C Wong1, Sumi Wijaya1, Kang-Nee Ting2, Christophe Wiart1, Kamarul'Ain Mustafa3, Fiona Shipton1, Teng-Jin Khoo1

Author Affiliations

1: Center for Natural and Medicinal Products Research, School of Pharmacy, Faculty of Science, University of Nottingham, Malaysia Campus, Jalan Broga, 43500 Semenyih, Selangor, Malaysia.
2: School of Biomedical, Faculty of Science, University of Nottingham, Malaysia Campus, Jalan Broga, 43500 Semenyih, Selangor, Malaysia.
3: Faculty of Chemistry, Universiti Sultan Zainal Abidin, Jalan Sultan Mahmud, 20400 Kuala Terengganu, Malaysia.

Articles cited by this

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem (1996) 28.76

Structural mechanism for statin inhibition of HMG-CoA reductase. Science (2001) 3.45

The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res (1992) 3.02

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther (2006) 1.97

Statins: mechanism of action and effects. J Cell Mol Med (2002) 1.62

Hypolipemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterolemic hamsters. Food Chem Toxicol (2005) 1.17

Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16

A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol (2003) 1.09

Phytomedicinal Role of Pithecellobium dulce against CCl(4)-mediated Hepatic Oxidative Impairments and Necrotic Cell Death. Evid Based Complement Alternat Med (2011) 0.97

Effects of Pithecellobium jiringa ethanol extract against ethanol-induced gastric mucosal injuries in Sprague-Dawley rats. Molecules (2012) 0.91

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay. J Lipid Res (1977) 0.90

Antimicrobial screening of ethnobotanically important stem bark of medicinal plants. Pharmacognosy Res (2010) 0.90

Redox properties and cytoprotective actions of atranorin, a lichen secondary metabolite. Toxicol In Vitro (2010) 0.88

Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression, adhesion molecules and oxidative stress in human coronary artery endothelial cells. Chin Med J (Engl) (2010) 0.87

Effects of Pithecellobium clypearia Benth extract and its main components on inflammation and allergy. Fitoterapia (2009) 0.86

Effect of the extract of the tamarind (Tamarindus indica) fruit on the complement system: studies in vitro and in hamsters submitted to a cholesterol-enriched diet. Food Chem Toxicol (2007) 0.84

Isolation and characterization of novel cytotoxic saponins from Archidendron ellipticum. Bioorg Med Chem (1997) 0.84

Screening of Yucatecan plant extracts to control Colletotrichum gloeosporioides and isolation of a New Pimarene from Acacia pennatula. J Agric Food Chem (2005) 0.82

Traditional extract of Pithecellobium dulce fruits protects mice against CCl(4) induced renal oxidative impairments and necrotic cell death. Pathophysiology (2012) 0.81

Purification and characterization of a trypsin-papain inhibitor from Pithecelobium dumosum seeds and its in vitro effects towards digestive enzymes from insect pests. Plant Physiol Biochem (2007) 0.81

Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations. Phys Chem Chem Phys (2011) 0.81

Antifungal activity of a new triterpenoid glycoside from Pithecellobium racemosum (M.). Pharm Res (1997) 0.79

The Role of Statin Therapy for Primary Prevention: What is the Evidence? Curr Atheroscler Rep (2012) 0.78

Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity. Appl Biochem Biotechnol (2010) 0.78

Protective effect of fluvastatin, an HMG-CoA reductase inhibitor, on the formation of 8-oxo-2'-deoxyguanosine in the nuclear DNA of hamster pancreas after a single administration of N-nitrosobis(2-oxopropyl)amine. Biol Pharm Bull (2003) 0.78